BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 2290210)

  • 1. [Assessment of the biological activity of residual or recurrent neuroblastoma tumors with 131I-metaiodobenzylguanidine (MIBG) scintigraphy].
    Murashima S; Takeda K; Okuda Y; Nakagawa T; Sakurai M
    Kaku Igaku; 1990 Dec; 27(12):1393-400. PubMed ID: 2290210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.
    Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Conte M; Villavecchia GP; Garaventa A; Lanino E; De Bernardi B; Scopinaro G
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):21-4. PubMed ID: 9002744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 131I-MIBG in the diagnosis of primary and metastatic neuroblastoma.
    El-Maghraby T
    Gulf J Oncolog; 2007 Jul; (2):33-41. PubMed ID: 20084722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical use of 131I-meta-iodo-benzylguanidine (MIBG) for the diagnosis of neuroblastoma.
    Zagar I; Mitrović S; Adanja G; Maksimović L; Ivanovski P; Han R; Kovacić K
    Med Pregl; 1993; 46 Suppl 1():74-5. PubMed ID: 8569615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 131I-meta-iodobenzylguanidine scintigraphy in patients with neuroblastoma.
    Hibi S; Todo S; Imashuku S; Miyazaki T
    Pediatr Radiol; 1987; 17(4):308-13. PubMed ID: 3601463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of I-131 metaiodobenzylguanidine (MIBG) imaging in suspected neuroblastoma].
    Iwashita S; Nakajo M; Nakabeppu Y; Tanoue T; Yonekura R; Taguchi M; Shimabukuro K; Shinohara S; Sakata H
    Kaku Igaku; 1989 Sep; 26(9):1135-47. PubMed ID: 2810911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of neural crest tumors by 123I-MIBG scintigraphy].
    Ikekubo K; Hino M; Ootsuka H; Ito H; Yamaguchi H; Dan Y; Masui Y; Bito S; Ohta K; Saiki Y
    Kaku Igaku; 1994 Nov; 31(11):1357-64. PubMed ID: 7837704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-111 pentetreotide scintigraphy in patients with neuroblastoma. Comparison with I-131 MIBG, N-Myc oncogene amplification, and patient outcome.
    Shalaby-Rana E; Majd M; Andrich MP; Movassaghi N
    Clin Nucl Med; 1997 May; 22(5):315-9. PubMed ID: 9152532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scanning with iodine-131 MIBG in children with solid tumors: an initial appraisal.
    Hadley GP; Rabe E
    J Nucl Med; 1986 May; 27(5):620-6. PubMed ID: 3712077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
    Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
    J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-meta-iodobenzylguanidine scintigraphy of neuroblastomas.
    Munkner T
    Semin Nucl Med; 1985 Apr; 15(2):154-60. PubMed ID: 4001964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [131I-MIBG-meta-iodobencylguanidine (131I-MIBG) in the study of neuroblastoma].
    Ferris J; Caballero O; Verdeguer A; Esquembre C; Castel V
    An Esp Pediatr; 1987 Mar; 26(3):164-70. PubMed ID: 3579055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive MIBG scanning at the time of relapse in neuroblastoma which was MIBG negative at diagnosis.
    Schwarz KB; Driver I; Lewis IJ; Taylor RE
    Br J Radiol; 1997 Jan; 70():90-2. PubMed ID: 9059302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The assessment of clinical usefulness of 131I-MIBG scintigraphy for localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
    Sasaki Y; Kubo A; Kusakabe K; Masaki H; Endo K; Yamashita M; Nakajo M; Kaneko M
    Kaku Igaku; 1992 Sep; 29(9):1083-98. PubMed ID: 1360549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity and specificity of meta-iodobenzylguanidine (mIBG) scintigraphy in the evaluation of neuroblastoma: analysis of 115 cases].
    Lumbroso J; Guermazi F; Hartmann O; Coornaert S; Rabarison Y; Lemerle J; Parmentier C
    Bull Cancer; 1988; 75(1):97-106. PubMed ID: 3359060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R; Lasorella A; Troncone L; Rufini V; Iavarone A; Riccardi R
    J Nucl Biol Med (1991); 1991; 35(4):252-4. PubMed ID: 1823829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-131 metaiodobenzylguanidine scintigraphy for the location of neuroblastoma: preliminary experience in ten cases.
    Geatti O; Shapiro B; Sisson JC; Hutchinson RJ; Mallette S; Eyre P; Beierwaltes WH
    J Nucl Med; 1985 Jul; 26(7):736-42. PubMed ID: 4009283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I-meta-iodobenzylguanidine in diagnosis and treatment of neuroblastoma.
    Voûte PA; Hoefnagel CA; de Kraker J
    Bull Cancer; 1988; 75(1):107-11. PubMed ID: 3359053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.